Free Trial

MarketBeat Instant News Alerts

AgomAb Therapeutics logo with Healthcare background

AgomAb Therapeutics (NASDAQ:AGMB) Stock: Insider David Epstein Buys 5,000 Shares

AgomAb Therapeutics NV (NASDAQ:AGMB - Get Free Report) Director David Epstein acquired 5,000 shares of the company's stock in a transaction that occurred on Tuesday, October 6th. The shares were acquired at an average cost of $8.70 per share, for a total transaction of $43,500.00. Following the completion of the transaction, the director directly owned 10,000 shares of the company's stock, valued at $87,000. The trade was a 100.00% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link.

NASDAQ:AGMB
Read AgomAb Therapeutics (NASDAQ:AGMB) Stock: Insider David Epstein Buys 5,000 Shares
AgomAb Therapeutics logo with Healthcare background

AgomAb Therapeutics (NASDAQ:AGMB) CEO Tim Jasper Knotnerus Acquires 5,000 Shares of Stock

AgomAb Therapeutics NV (NASDAQ:AGMB - Get Free Report) CEO Tim Jasper Knotnerus bought 5,000 shares of AgomAb Therapeutics stock in a transaction dated Tuesday, October 6th. The stock was acquired at an average price of $8.70 per share, with a total value of $43,500.00. Following the acquisition, the chief executive officer directly owned 21,823 shares of the company's stock, valued at approximately $189,860.10. This represents a 29.72% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

NASDAQ:AGMB
Read AgomAb Therapeutics (NASDAQ:AGMB) CEO Tim Jasper Knotnerus Acquires 5,000 Shares of Stock
AgomAb Therapeutics logo with Healthcare background

AgomAb Therapeutics (NASDAQ:AGMB) CEO Purchases 6,000 Shares of Stock

AgomAb Therapeutics NV (NASDAQ:AGMB - Get Free Report) CEO Tim Jasper Knotnerus acquired 6,000 shares of the company's stock in a transaction dated Monday, October 5th. The stock was acquired at an average cost of $8.48 per share, for a total transaction of $50,880.00. Following the completion of the acquisition, the chief executive officer directly owned 16,823 shares in the company, valued at approximately $142,659.04. The trade was a 55.44% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink.

NASDAQ:AGMB
Read AgomAb Therapeutics (NASDAQ:AGMB) CEO Purchases 6,000 Shares of Stock
AgomAb Therapeutics logo with Healthcare background

Insider Buying: AgomAb Therapeutics (NASDAQ:AGMB) CFO Purchases 10,000 Shares of Company Stock

AgomAb Therapeutics NV (NASDAQ:AGMB - Get Free Report) CFO Pierre Thadee Victor Kemula bought 10,000 shares of the stock in a transaction that occurred on Tuesday, October 6th. The shares were purchased at an average price of $8.59 per share, for a total transaction of $85,900.00. Following the completion of the acquisition, the chief financial officer owned 10,000 shares of the company's stock, valued at $85,900. The trade was a ∞ increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

NASDAQ:AGMB
Read Insider Buying: AgomAb Therapeutics (NASDAQ:AGMB) CFO Purchases 10,000 Shares of Company Stock
UWM logo with Finance background

UWM (NYSE:UWMC) Stock Rating Lowered by Keefe, Bruyette & Woods

Keefe, Bruyette & Woods downgraded shares of UWM from an "outperform" rating to a "market perform" rating and set a $1.50 price target for the company. in a research note on Wednesday.

NYSE:UWMC
Read UWM (NYSE:UWMC) Stock Rating Lowered by Keefe, Bruyette & Woods
Moelis & Company logo with Finance background

Moelis & Company (NYSE:MC) Raised to Neutral at UBS Group

UBS Group upgraded Moelis & Company from a "sell" rating to a "neutral" rating and set a $59.00 price target on the stock in a research note on Wednesday.

NYSE:MC
Read Moelis & Company (NYSE:MC) Raised to Neutral at UBS Group

Trending News

All MarketBeat Instant News Alerts

TransMedics Group logo with Healthcare background

TransMedics Group (NASDAQ:TMDX) Now Covered by Analysts at Barclays

NASDAQ:TMDX
Read TransMedics Group (NASDAQ:TMDX) Now Covered by Analysts at Barclays
Senseonics Holdings, Inc. Common Stock logo with Healthcare background

Barclays Begins Coverage on Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS)

NASDAQ:SENS
Read Barclays Begins Coverage on Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS)
MiniMed Group logo with Healthcare background

MiniMed Group (NASDAQ:MMED) Now Covered by Analysts at Barclays

NASDAQ:MMED
Read MiniMed Group (NASDAQ:MMED) Now Covered by Analysts at Barclays
Better Home & Finance logo with Finance background

Better Home & Finance Unveils 90-Day Turnaround Plan, Targets Breakeven With HELOC Push

NASDAQ:BETR
Read Better Home & Finance Unveils 90-Day Turnaround Plan, Targets Breakeven With HELOC Push
Rocket Pharmaceuticals logo with Healthcare background

Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Keeps "Outperform" Rating at Wedbush

NASDAQ:RCKT
Read Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Keeps "Outperform" Rating at Wedbush
Zscaler logo with Technology background

Zscaler (NASDAQ:ZS) Stock Price Target Raised at Wedbush

NASDAQ:ZS
Read Zscaler (NASDAQ:ZS) Stock Price Target Raised at Wedbush
Albemarle logo with Materials background

Albemarle (NYSE:ALB) Price Target Cut to $135.00 by Analysts at Argus

NYSE:ALB
Read Albemarle (NYSE:ALB) Price Target Cut to $135.00 by Analysts at Argus
International Flavors & Fragrances logo with Materials background

International Flavors & Fragrances (NYSE:IFF) Price Target Raised to $95.00

NYSE:IFF
Read International Flavors & Fragrances (NYSE:IFF) Price Target Raised to $95.00
Baxter International logo with Healthcare background

Barclays Initiates Coverage on Baxter International (NYSE:BAX)

NYSE:BAX
Read Barclays Initiates Coverage on Baxter International (NYSE:BAX)
Ambev logo with Consumer Staples background

Ambev (NYSE:ABEV) Stock Keeps "Underperform" Rating at Bank of America

NYSE:ABEV
Read Ambev (NYSE:ABEV) Stock Keeps "Underperform" Rating at Bank of America
American Airlines Group logo with Industrials background

Susquehanna Issues Pessimistic Forecast for American Airlines Group (NASDAQ:AAL) Stock Price

NASDAQ:AAL
Read Susquehanna Issues Pessimistic Forecast for American Airlines Group (NASDAQ:AAL) Stock Price
Allegiant Travel logo with Industrials background

Susquehanna Cuts Allegiant Travel (NASDAQ:ALGT) Price Target to $85.00

NASDAQ:ALGT
Read Susquehanna Cuts Allegiant Travel (NASDAQ:ALGT) Price Target to $85.00
Alaska Air Group logo with Industrials background

Susquehanna Issues Pessimistic Forecast for Alaska Air Group (NYSE:ALK) Stock Price

NYSE:ALK
Read Susquehanna Issues Pessimistic Forecast for Alaska Air Group (NYSE:ALK) Stock Price
Delta Air Lines logo with Industrials background

Delta Air Lines (NYSE:DAL) Stock Price Target Lowered at Susquehanna

NYSE:DAL
Read Delta Air Lines (NYSE:DAL) Stock Price Target Lowered at Susquehanna
JetBlue Airways logo with Industrials background

Susquehanna Issues Pessimistic Forecast for JetBlue Airways (NASDAQ:JBLU) Stock Price

NASDAQ:JBLU
Read Susquehanna Issues Pessimistic Forecast for JetBlue Airways (NASDAQ:JBLU) Stock Price
Carrier Global logo with Industrials background

Carrier Global (NYSE:CARR) Given New $64.00 Price Target at Sanford C. Bernstein

NYSE:CARR
Read Carrier Global (NYSE:CARR) Given New $64.00 Price Target at Sanford C. Bernstein
Southwest Airlines logo with Industrials background

Susquehanna Issues Pessimistic Forecast for Southwest Airlines (NYSE:LUV) Stock Price

NYSE:LUV
Read Susquehanna Issues Pessimistic Forecast for Southwest Airlines (NYSE:LUV) Stock Price
Marvell Technology logo with Technology background

Marvell Technology (NASDAQ:MRVL) Stock Price Target Raised at Susquehanna

NASDAQ:MRVL
Read Marvell Technology (NASDAQ:MRVL) Stock Price Target Raised at Susquehanna
SpaceX logo with Communication Services background

SpaceX (NASDAQ:SPCX) Stock Price Target Raised at Susquehanna

NASDAQ:SPCX
Read SpaceX (NASDAQ:SPCX) Stock Price Target Raised at Susquehanna
United Airlines logo with Industrials background

United Airlines (NASDAQ:UAL) Stock Price Target Cut by Susquehanna

NASDAQ:UAL
Read United Airlines (NASDAQ:UAL) Stock Price Target Cut by Susquehanna
Rocket Pharmaceuticals logo with Healthcare background

Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Rating Reaffirmed as Buy by Chardan Capital

NASDAQ:RCKT
Read Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Rating Reaffirmed as Buy by Chardan Capital
Frontier Group logo with Industrials background

Susquehanna Issues Pessimistic Forecast for Frontier Group (NASDAQ:ULCC) Stock Price

NASDAQ:ULCC
Read Susquehanna Issues Pessimistic Forecast for Frontier Group (NASDAQ:ULCC) Stock Price
Hut 8 logo with Technology background

Hut 8's (HUT) "Buy" Rating Reaffirmed at Canaccord Genuity Group

NASDAQ:HUT
Read Hut 8's (HUT) "Buy" Rating Reaffirmed at Canaccord Genuity Group
ServiceNow logo with Technology background

Argus Forecasts Strong Price Appreciation for ServiceNow (NYSE:NOW) Stock

NYSE:NOW
Read Argus Forecasts Strong Price Appreciation for ServiceNow (NYSE:NOW) Stock

Featured Articles and Offers

Alert Categories

All Alerts